Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP627682.RA747jsaMLd1BYfvWwj8mWGyRmB9PyReQ68kD-N4rDkyo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP627682.RA747jsaMLd1BYfvWwj8mWGyRmB9PyReQ68kD-N4rDkyo130_assertion type Assertion NP627682.RA747jsaMLd1BYfvWwj8mWGyRmB9PyReQ68kD-N4rDkyo130_head.
- NP627682.RA747jsaMLd1BYfvWwj8mWGyRmB9PyReQ68kD-N4rDkyo130_assertion description "[CSS has 2 major clinical subsets, antineutrophil cytoplasmic antibody (ANCA)-positive, with features of small-vessel vasculitis, and ANCA-negative, in which organ damage is mainly mediated by tissue eosinophilic infiltration; analysis of HLA-DRB4 in patients categorized by different numbers of vasculitic manifestations (purpura, alveolar hemorrhage, mononeuritis multiplex, rapidly progressive glomerulonephritis, and constitutional symptoms) showed that its frequency strongly correlated with the number of vasculitis symptoms (P for trend = 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP627682.RA747jsaMLd1BYfvWwj8mWGyRmB9PyReQ68kD-N4rDkyo130_provenance.
- NP627682.RA747jsaMLd1BYfvWwj8mWGyRmB9PyReQ68kD-N4rDkyo130_assertion evidence source_evidence_literature NP627682.RA747jsaMLd1BYfvWwj8mWGyRmB9PyReQ68kD-N4rDkyo130_provenance.
- NP627682.RA747jsaMLd1BYfvWwj8mWGyRmB9PyReQ68kD-N4rDkyo130_assertion SIO_000772 17763415 NP627682.RA747jsaMLd1BYfvWwj8mWGyRmB9PyReQ68kD-N4rDkyo130_provenance.
- NP627682.RA747jsaMLd1BYfvWwj8mWGyRmB9PyReQ68kD-N4rDkyo130_assertion wasDerivedFrom befree-2016 NP627682.RA747jsaMLd1BYfvWwj8mWGyRmB9PyReQ68kD-N4rDkyo130_provenance.
- NP627682.RA747jsaMLd1BYfvWwj8mWGyRmB9PyReQ68kD-N4rDkyo130_assertion wasGeneratedBy ECO_0000203 NP627682.RA747jsaMLd1BYfvWwj8mWGyRmB9PyReQ68kD-N4rDkyo130_provenance.